Immunotherapy found to be effective for the treatment of basal cell carcinoma skin cancer
Those who received a third dose of the COVID-19 vaccine are 85.6% less likely to contract the disease compared to people who were only vaccinated twice.
Doctors at Sheba Medical Center performed a transcatheter mitral valve replacement on a 74-year-old patient using the cutting-edge LAMPOON technique.
With VIDA, Sheba offers earlier and more accurate detection of breast cancer
Forbes’ Best Doctors in Israel List includes 1,350 clinicians, 216 of which are Sheba’s own.
The agreement involves sharing knowledge, conducting joint research, training staff, and more.
Research suggests a significant decrease in immune response a few months after receiving the second dose of the Pfizer-BioNTech COVID-19 vaccine
Researchers were awarded a 2.1 million USD grant that will fund the next step of the study.
Sheba’s Prof. Dudkiewicz visited UAE hospitals to share his unique know-how.
global patient services
Global Patient Services at Sheba
CONTACT SHEBA MEDICAL CENTER
The information on this website is for general knowledge purposes only and does not constitute medical advice, diagnosis, or treatment in any form. It is not a substitute for professional medical advice from a qualified physician.
Additionally, you are browsing the official – and only – website of Sheba Medical Center and not an agent or affiliate website.